4//SEC Filing
SUTTER MARTIN P 4
Accession 0001415889-22-008776
CIK 0000815094other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 5:09 PM ET
Size
35.6 KB
Accession
0001415889-22-008776
Insider Transaction Report
Form 4
ABIOMED INCNASD
SUTTER MARTIN P
Director
Transactions
- Sale
Common Stock, $0.01 par value
2022-08-16$292.47/sh−145$42,408→ 124,921 total - Sale
Common Stock, $0.01 par value
2022-08-16$287.66/sh−51$14,671→ 126,788 total - Sale
Common Stock, $0.01 par value
2022-08-17$281.52/sh−785$220,990→ 123,481 total - Sale
Common Stock, $0.01 par value
2022-08-17$282.39/sh−184$51,960→ 123,297 total - Sale
Common Stock, $0.01 par value
2022-08-17$285.59/sh−77$21,990→ 122,937 total - Sale
Common Stock, $0.01 par value
2022-08-17$287.44/sh−20$5,749→ 122,839 total - Sale
Common Stock, $0.01 par value
2022-08-16$288.44/sh−285$82,204→ 126,503 total - Sale
Common Stock, $0.01 par value
2022-08-16$290.60/sh−483$140,360→ 125,906 total - Sale
Common Stock, $0.01 par value
2022-08-16$291.33/sh−840$244,721→ 125,066 total - Sale
Common Stock, $0.01 par value
2022-08-16$289.63/sh−114$33,018→ 126,389 total - Sale
Common Stock, $0.01 par value
2022-08-16$293.44/sh−82$24,062→ 124,839 total - Sale
Common Stock, $0.01 par value
2022-08-17$284.44/sh−78$22,186→ 123,014 total - Sale
Common Stock, $0.01 par value
2022-08-17$280.59/sh−573$160,776→ 124,266 total - Sale
Common Stock, $0.01 par value
2022-08-17$283.51/sh−205$58,119→ 123,092 total - Sale
Common Stock, $0.01 par value
2022-08-17$286.49/sh−78$22,346→ 122,859 total
Footnotes (16)
- [F1]Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- [F10]This price represents the sale price of the transactions on the reported date at $281.5165. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F11]This price represents the sale price of the transactions on the reported date at $282.3938. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F12]This price represents the sale price of the transactions on the reported date at $283.5060. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F13]This price represents the sale price of the transactions on the reported date at $284.4379. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F14]This price represents the sale price of the transactions on the reported date at $285.5858. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F15]This price represents the sale price of the transactions on the reported date at $286.4935. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F16]This price represents the sale price of the transactions on the reported date at $287.4400. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F2]This price represents the sale price of the transactions on the reported date at $287.6629. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F3]This price represents the sale price of the transactions on the reported date at $288.4350. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F4]This price represents the sale price of the transactions on the reported date at $289.6287. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F5]This price represents the sale price of the transactions on the reported date at $290.6014. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F6]This price represents the sale price of the transactions on the reported date at $291.3347. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F7]This price represents the sale price of the transactions on the reported date at $292.4712. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F8]This price represents the sale price of the transactions on the reported date at $293.4404. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F9]This price represents the sale price of the transactions on the reported date at $280.5863. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Documents
Issuer
ABIOMED INC
CIK 0000815094
Entity typeother
Related Parties
1- filerCIK 0001017832
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 5:09 PM ET
- Size
- 35.6 KB